A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson's disease.

ABSTRACT:

Background

The aim of this study was to evaluate the efficacy of a group Cognitive Behavioural Therapy (CBT) treatment for depression and anxiety in Parkinson's disease (PD).

Methods

A waitlist-controlled trial design was used. Eighteen adults with PD and a comorbid DSM-IV-TR diagnosis of depression and/or anxiety were randomised to either Intervention (8-week group CBT treatment) or Waitlist (8-week clinical monitoring preceding treatment). The Depression, Anxiety, Stress Scale-21 (DASS-21) was the primary outcome. Assessments were completed at Time 1 (pretreatment), Time 2 (posttreatment/post-waitlist) and 1-month and 6-month follow-ups.

Results

At Time 2, participants who received CBT reported greater reductions in depression (M(change) = -2.45) than Waitlist parti

SUBMITTER: Troeung L 

PROVIDER: S-EPMC3907935 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature